Marc S. Tyndel

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim et al. · Blood · 2016 · 139 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

Tae‐Hyung Kim, Joon Ho Moon, Jae-Sook Ahn et al. · Blood · 2018 · 110 citations · Full text

Medicine, Hematology, Oncology +15

The clonal origins of leukemic progression of myelodysplasia

T Kim, Marc S. Tyndel, Hyeong‐Joon Kim et al. · Leukemia · 2017 · 50 citations · Full text

Medicine, Genetics, Hematology +14

MUSI: an integrated system for identifying multiple specificity from very large peptide or nucleic acid data sets

Tae‐Hyung Kim, Marc S. Tyndel, Haiming Huang et al. · Nucleic Acids Research · 2011 · 49 citations · Full text

Life Sciences, Biology, Molecular Biology +14

Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy

Tae‐Hyung Kim, Marc S. Tyndel, Zhaolei Zhang et al. · Leukemia Research · 2017 · 36 citations

Medicine, Genetics, Oncology +12